Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-12-23
1999-10-12
Mach, D. Margaret M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514256, 514277, 514365, 514381, 514372, 5142312, 514482, 514506, 514520, 514553, A01N 3710, A01N 3734, A01N 4354
Patent
active
059656190
ABSTRACT:
Substituted indene derivatives are useful for treating patients having precancerous lesions and for inhibiting the growth of neoplastic cells.
REFERENCES:
patent: 3161654 (1964-12-01), Shen
patent: 3312730 (1967-04-01), Winter
patent: 3325358 (1967-06-01), Winter et al.
patent: 3532752 (1970-10-01), Shen
patent: 3609184 (1971-09-01), Miyai et al.
patent: 3622623 (1971-11-01), Shen et al.
patent: 3631167 (1971-12-01), Shen
patent: 3642785 (1972-02-01), Shen et al.
patent: 3647858 (1972-03-01), Hinkley et al.
patent: 3654349 (1972-04-01), Shen et al.
patent: 3692651 (1972-09-01), Sletzinger
patent: 3692825 (1972-09-01), Conn
patent: 3700730 (1972-10-01), Hinkley
patent: 3737455 (1973-06-01), Shen et al.
patent: 3759987 (1973-09-01), Conn
patent: 3766259 (1973-10-01), Sletzinger
patent: 3772282 (1973-11-01), Ford, Jr.
patent: 3812109 (1974-05-01), Shen et al.
patent: 3812180 (1974-05-01), Shen et al.
patent: 3822310 (1974-07-01), Shen et al.
patent: 3851063 (1974-11-01), Shen et al.
patent: 3860636 (1975-01-01), Shen et al.
patent: 3868414 (1975-02-01), Shen et al.
patent: 3868415 (1975-02-01), Jones
patent: 3869507 (1975-03-01), Jones
patent: 3870753 (1975-03-01), Tull et al.
patent: 3888902 (1975-06-01), Shen et al.
patent: 3897487 (1975-07-01), Jones
patent: 3932498 (1976-01-01), Shen et al.
patent: 3944600 (1976-03-01), Tull et al.
patent: 3954852 (1976-05-01), Shen
patent: 3956363 (1976-05-01), Shen et al.
patent: 3970693 (1976-07-01), Tull et al.
patent: 3998875 (1976-12-01), Tull et al.
patent: 4207340 (1980-06-01), Gardocki
patent: 4233457 (1980-11-01), Czaja et al.
patent: 4307114 (1981-12-01), Dvornik et al.
patent: 4402979 (1983-09-01), Shen et al.
patent: 4423074 (1983-12-01), Dvornik et al.
patent: 4423075 (1983-12-01), Dvornik et al.
patent: 4656190 (1987-04-01), Shen et al.
patent: 4748271 (1988-05-01), Meneghin
patent: 4943587 (1990-07-01), Cetenko et al.
patent: 5112868 (1992-05-01), Cetenko et al.
patent: 5229516 (1993-07-01), Musser et al.
patent: 5401774 (1995-03-01), Pamukcu
patent: 5420289 (1995-05-01), Musser
Waddell, W.R. et al., Am. J. Surgery, vol. 157, pp. 175-179 (1989).
Gonzaga, R.A.F. et al., The Lancet, Mar. 30, 1985, p. 751.
Waddell, W.R. et al., J. Surg. Oncology, vol. 24, pp. 83-87 (1983).
Federation Proceedings (1972) of the Federation of American Societies for Experimental Biology abstract Nos. 2044 and 2045.
Gilman, S.C. et al., Nonsteroidal Anti-inflammatory Drugs in Cancer Therapy, (circa 1985), pp. 157-179.
Brogden, R.N. et al., Drugs, vol. 16, pp. 97-114 (1978).
Hucker, H.B. et al., Drug Metabolism & Disposition, vol. 1, No. 6, pp. 721-736 (1973).
Shen, T.Y. et al., Chemical and Biological Studies on Indomethacin, Sulindac and Their Analogs, pp. 107-178 (circa 1975).
Duggan, D.E. et al., Clin. Pharm. & Therapeutics, vol. 21, No. 3, pp. 326-335 (1976).
Duggan, D.E. et al., J. Pharm. & Exper. Therap., vol. 201, No. 1, pp. 8-13 (1977).
Glavin, G.B. et al., Toxicology and Applied Pharmacology, vol. 83, pp. 386-389 (1986).
Moorghen, M. et al., Journal of Pathology, vol. 156, pp. 341-347 (1988).
Moorghen, M. et al., Acta Histochemica, Suppl.-Band XXIX, S. 195-199 (1990).
Bjarnason et al., Gastroenterology, vol. 94, No. 4, pp. 1070-1074 (1988).
Brendel Klaus
Gross Paul
Pamukcu Rifat
Piazza Gary A.
Sperl Gerhard
Cell Pathways Inc.
M. Mach D. Margaret
Stevenson Robert W.
LandOfFree
Method for treating patients having precancerous lesions with su does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating patients having precancerous lesions with su, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating patients having precancerous lesions with su will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-653179